[{"address1": "1000 Skokie Boulevard", "address2": "Suite 350", "city": "Wilmette", "state": "IL", "zip": "60091", "country": "United States", "phone": "847 388 0349", "website": "https://www.monopartx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral medicine; MNPR-101, a proprietary humanized monoclonal antibody that is conjugated with different radioisotopes for the treatment of advanced solid tumors expressing urokinase plasminogen activator receptor; and MNPR-101-Zr, a clinical-stage radiodiagnostic imaging agent comprised of MNPR-101 conjugated to zirconium-89. It develops MNPR-101-Lu, a late-preclinical stage radiotherapeutic comprised of MNPR-101 conjugated to actinium-225. The company has collaborations NorthStar to develop radio-immuno-therapeutics targeting severe COVID-19. The company was founded in 2014 and is headquartered in Wilmette, Illinois.", "fullTimeEmployees": 14, "companyOfficers": [{"maxAge": 1, "name": "Dr. Christopher M. Starr Ph.D.", "age": 72, "title": "Co-Founder & Independent Executive Chairman of the Board", "yearBorn": 1952, "fiscalYear": 2024, "totalPay": 200000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Chandler D. Robinson M.B.A., M.D., M.Sc., MBA, MSc", "age": 40, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1984, "fiscalYear": 2024, "totalPay": 1144480, "exercisedValue": 0, "unexercisedValue": 760281}, {"maxAge": 1, "name": "Mr. Andrew J. Cittadine M.B.A.", "age": 52, "title": "Chief Operating Officer", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 542544, "exercisedValue": 0, "unexercisedValue": 179487}, {"maxAge": 1, "name": "Mr. Quan Anh Vu", "age": 55, "title": "CFO, Principal accounting officer & Principal financial officer", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Patrice P. Rioux M.D., Ph.D.", "age": 73, "title": "Acting Chief Medical Officer", "yearBorn": 1951, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 10, "compensationRisk": 9, "shareHolderRightsRisk": 2, "overallRisk": 8, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 87.36, "open": 90.98, "dayLow": 84.0, "dayHigh": 91.79, "regularMarketPreviousClose": 87.36, "regularMarketOpen": 90.98, "regularMarketDayLow": 84.0, "regularMarketDayHigh": 91.79, "payoutRatio": 0.0, "beta": 1.466, "forwardPE": -36.516953, "volume": 50642, "regularMarketVolume": 50642, "averageVolume": 105216, "averageVolume10days": 148520, "averageDailyVolume10Day": 148520, "bid": 85.58, "ask": 89.0, "bidSize": 1, "askSize": 5, "marketCap": 575905088, "fiftyTwoWeekLow": 20.16, "fiftyTwoWeekHigh": 105.0, "allTimeHigh": 240.0, "allTimeLow": 1.37, "fiftyDayAverage": 83.6997, "twoHundredDayAverage": 49.2389, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 432331552, "profitMargins": 0.0, "floatShares": 3916529, "sharesOutstanding": 6682584, "sharesShort": 371120, "sharesShortPriorMonth": 161927, "sharesShortPreviousMonthDate": 1760486400, "dateShortInterest": 1763078400, "sharesPercentSharesOut": 0.0555, "heldPercentInsiders": 0.23757, "heldPercentInstitutions": 0.65007, "shortRatio": 2.78, "shortPercentOfFloat": 0.14829999, "impliedSharesOutstanding": 6682584, "bookValue": 21.246, "priceToBook": 4.056293, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -19441708, "trailingEps": -3.96, "forwardEps": -2.36, "lastSplitFactor": "1:5", "lastSplitDate": 1723507200, "52WeekChange": 2.969105, "SandP52WeekChange": 0.1265819, "quoteType": "EQUITY", "currentPrice": 86.18, "targetHighPrice": 130.0, "targetLowPrice": 93.0, "targetMeanPrice": 111.76923, "targetMedianPrice": 109.0, "recommendationMean": 1.23077, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 13, "totalCash": 143675792, "totalCashPerShare": 21.5, "totalDebt": 102236, "quickRatio": 55.937, "currentRatio": 56.098, "debtToEquity": 0.072, "returnOnAssets": -0.17988001, "returnOnEquity": -0.26541, "freeCashflow": -8453437, "operatingCashflow": -10829637, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "MNPR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1764362340, "regularMarketTime": 1764363600, "exchange": "NCM", "messageBoardId": "finmb_304391755", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.350733, "regularMarketPrice": 86.18, "shortName": "Monopar Therapeutics Inc.", "longName": "Monopar Therapeutics Inc.", "marketState": "CLOSED", "epsTrailingTwelveMonths": -3.96, "epsForward": -2.36, "epsCurrentYear": -1.676, "priceEpsCurrentYear": -51.420048, "fiftyDayAverageChange": 2.480301, "fiftyDayAverageChangePercent": 0.02963333, "twoHundredDayAverageChange": 36.9411, "twoHundredDayAverageChangePercent": 0.75024223, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1576765800000, "postMarketChangePercent": -0.32489994, "postMarketPrice": 85.9, "postMarketChange": -0.27999878, "regularMarketChange": -1.1800003, "regularMarketDayRange": "84.0 - 91.79", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 105216, "fiftyTwoWeekLowChange": 66.020004, "fiftyTwoWeekLowChangePercent": 3.2748017, "fiftyTwoWeekRange": "20.16 - 105.0", "fiftyTwoWeekHighChange": -18.82, "fiftyTwoWeekHighChangePercent": -0.1792381, "fiftyTwoWeekChangePercent": 296.9105, "earningsTimestamp": 1763040600, "earningsTimestampStart": 1763040600, "earningsTimestampEnd": 1763040600, "isEarningsDateEstimate": false, "displayName": "Monopar Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-11-29"}]